Characterization of ceftazidime resistance mechanisms in clinical isolates of Burkholderia pseudomallei from Australia.
about
Burkholderia pseudomallei isolates from Sarawak, Malaysian Borneo, are predominantly susceptible to aminoglycosides and macrolidesWithin-Host Evolution of Burkholderia pseudomallei during Chronic Infection of Seven Australasian Cystic Fibrosis Patients.Rapid Burkholderia pseudomallei identification and antibiotic resistance determination by bacteriophage amplification and MALDI-TOF MS.Antimicrobial susceptibility pattern of clinical isolates of Burkholderia pseudomallei in BangladeshThe tandem repeats enabling reversible switching between the two phases of β-lactamase substrate spectrum.Twelve positions in a β-lactamase that can expand its substrate spectrum with a single amino acid substitution.Treatment and prophylaxis of melioidosisDiverse Burkholderia Species Isolated from Soils in the Southern United States with No Evidence of B. pseudomalleiExposing a β-Lactamase "Twist": the Mechanistic Basis for the High Level of Ceftazidime Resistance in the C69F Variant of the Burkholderia pseudomallei PenI β-Lactamase.Membrane-Bound PenA β-Lactamase of Burkholderia pseudomalleiBacterial gene loss as a mechanism for gain of antimicrobial resistance.Within-host evolution of Burkholderia pseudomallei over a twelve-year chronic carriage infectionDiscovery of Inhibitors of Burkholderia pseudomallei Methionine Aminopeptidase with Antibacterial Activity.Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis.Melioidosis and the kidney.Melioidosis: molecular aspects of pathogenesis.Loss of Methyltransferase Function and Increased Efflux Activity Leads to Doxycycline Resistance in Burkholderia pseudomallei.Phylogeographic, genomic, and meropenem susceptibility analysis of Burkholderia ubonensis.Antibiotic resistance in Burkholderia speciesDevelopment of ceftazidime resistance in an acute Burkholderia pseudomallei infection.Substrate spectrum extension of PenA in Burkholderia thailandensis with a single amino acid deletion, Glu168delAntibiotic Resistance Markers in Burkholderia pseudomallei Strain Bp1651 Identified by Genome Sequence Analysis.Diversity and regulation of intrinsic β-lactamases from non-fermenting and other Gram-negative opportunistic pathogens.Antimicrobial resistance (AMR) nanomachines-mechanisms for fluoroquinolone and glycopeptide recognition, efflux and/or deactivation.Antimicrobial susceptibility and genetic characterisation of Burkholderia pseudomallei isolated from Malaysian patients.Transcriptional and post-transcriptional regulation of PenA β-lactamase in acquired Burkholderia pseudomallei β-lactam resistance.Evaluating New Compounds to Treat Infections
P2860
Q28300674-66136B85-FDB4-43E9-82C4-8462A0B83913Q33555304-076651EC-D390-486D-8067-5C478ABB7885Q33877994-9F2C3051-5960-43A1-8EB8-D8731D043BDCQ33921823-9BF235C0-7C59-4D06-98E7-DAF59DABE5A5Q34214749-1FDB9F71-3F44-40DA-867E-BE93FB87D585Q34282016-C9D13C94-367F-43A6-9F50-8560563C1B64Q34538191-65221940-A709-4709-AD50-3834AB6C66FAQ35850715-BFC60AE1-D6C5-4747-88EF-74F64D212490Q36571985-83B009BF-2AF8-4D4C-B443-FBED693B5D1FQ36644825-739C6085-82F7-477F-AA49-BB378AA39F47Q37015333-3B19808B-B8AE-4696-8F2D-06C0B4847F29Q37074494-BD26364B-C83B-46AE-ADAF-D0067E4751E8Q37410489-58B44EE9-738E-4968-A0C7-922E9F10C771Q38066577-62CFDDDF-635A-4299-84E3-D23922E74256Q38070912-BC8627E6-5613-495B-A866-F64DCB7C76F8Q38259874-6F15F593-4929-49DF-A59F-5E7D31758414Q39582866-B230376F-10CF-4238-BCC4-ABD2ED1DC2B1Q40046274-C591014F-5F39-4EA4-A346-AE48941E31BBQ40542863-D932D288-825E-44AD-A832-99284B2AA049Q41874947-EC4BD307-4C1B-4D55-B41D-F2ABD81010DDQ42110602-6DA00723-CAB9-4EF2-917B-A6AF566A5F30Q44423713-EBC71C04-1365-42FD-ACC2-3AF5C8AC94D6Q46286684-9BAB61E1-40D4-4EE8-9C33-0D416F889506Q52360303-68E8500F-298D-4186-9BAE-4020122E241CQ55630844-C3241624-0446-427F-A333-A008DBFE48C0Q55715517-F056A54C-5706-4E45-9D27-A70C4FED9235Q56375673-1C588937-038D-44EE-9FE6-6D0E22D34F16
P2860
Characterization of ceftazidime resistance mechanisms in clinical isolates of Burkholderia pseudomallei from Australia.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Characterization of ceftazidim ...... a pseudomallei from Australia.
@ast
Characterization of ceftazidim ...... a pseudomallei from Australia.
@en
Characterization of ceftazidim ...... a pseudomallei from Australia.
@nl
type
label
Characterization of ceftazidim ...... a pseudomallei from Australia.
@ast
Characterization of ceftazidim ...... a pseudomallei from Australia.
@en
Characterization of ceftazidim ...... a pseudomallei from Australia.
@nl
prefLabel
Characterization of ceftazidim ...... a pseudomallei from Australia.
@ast
Characterization of ceftazidim ...... a pseudomallei from Australia.
@en
Characterization of ceftazidim ...... a pseudomallei from Australia.
@nl
P2093
P2860
P50
P1433
P1476
Characterization of ceftazidim ...... a pseudomallei from Australia.
@en
P2093
David M Engelthaler
David M Wagner
James M Cook
Leisha Richardson
Lindsey M Watson
Meagan L Seymour
P2860
P304
P356
10.1371/JOURNAL.PONE.0030789
P407
P50
P577
2012-02-21T00:00:00Z